Baxter - 39 Year Stock Price History | BAX
Historical daily share price chart and data for Baxter since 1981 adjusted for splits. The latest closing stock price for Baxter as of September 28, 2020 is 79.54.
- The all-time high Baxter stock closing price was 94.14 on April 20, 2020.
- The Baxter 52-week high stock price is 95.19, which is 19.7% above the current share price.
- The Baxter 52-week low stock price is 69.10, which is 13.1% below the current share price.
- The average Baxter stock price for the last 52 weeks is 85.09.
| Baxter Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2020 | 85.8929 | 85.8700 | 94.1400 | 71.5700 | 79.5400 | -4.88% |
| 2019 | 79.7233 | 65.3000 | 89.7800 | 64.4800 | 83.6200 | 27.04% |
| 2018 | 69.8944 | 67.1700 | 77.8000 | 61.4500 | 65.8200 | 1.83% |
| 2017 | 58.0264 | 44.4400 | 66.0500 | 44.4400 | 64.6400 | 45.78% |
| 2016 | 43.8994 | 37.1700 | 49.1600 | 34.7600 | 44.3400 | 16.23% |
| 2015 | 52.9969 | 73.3100 | 73.3100 | 32.2700 | 38.1500 | -47.95% |
| 2014 | 72.2730 | 69.1900 | 77.0000 | 66.4900 | 73.2900 | 5.38% |
| 2013 | 69.3542 | 67.6500 | 74.4300 | 63.8900 | 69.5500 | 4.34% |
| 2012 | 58.0275 | 50.5400 | 68.8100 | 49.0300 | 66.6600 | 34.72% |
| 2011 | 54.3502 | 50.5500 | 62.4100 | 47.6500 | 49.4800 | -2.25% |
| 2010 | 49.9003 | 58.2900 | 61.7100 | 40.4700 | 50.6200 | -13.74% |
| 2009 | 54.0204 | 55.0800 | 60.5000 | 46.4100 | 58.6800 | 9.50% |
| 2008 | 61.4454 | 57.7900 | 71.1500 | 48.5000 | 53.5900 | -7.68% |
| 2007 | 54.7795 | 46.5000 | 61.0900 | 46.3300 | 58.0500 | 25.13% |
| 2006 | 40.9353 | 38.3600 | 47.2100 | 35.4500 | 46.3900 | 23.21% |
| 2005 | 37.2682 | 34.6200 | 40.9500 | 33.3700 | 37.6500 | 9.00% |
| 2004 | 31.4834 | 30.1700 | 34.5900 | 28.7600 | 34.5400 | 13.17% |
| 2003 | 26.5806 | 28.6900 | 31.2000 | 18.5600 | 30.5200 | 9.00% |
| 2002 | 43.1442 | 53.1000 | 59.6000 | 24.2200 | 28.0000 | -47.79% |
| 2001 | 48.4272 | 44.8150 | 55.5000 | 40.7500 | 53.6300 | 21.46% |
| 2000 | 35.8150 | 30.6900 | 44.4400 | 25.9050 | 44.1550 | 40.60% |
| 1999 | 32.7239 | 31.5950 | 37.9700 | 29.3450 | 31.4050 | -2.24% |
| 1998 | 28.6442 | 25.0650 | 33.0000 | 24.3450 | 32.1250 | 27.38% |
| 1997 | 25.1378 | 20.3150 | 29.7500 | 20.3150 | 25.2200 | 23.02% |
| 1996 | 21.9332 | 20.8100 | 23.9375 | 20.0000 | 20.5000 | -2.10% |
| 1995 | 17.7909 | 14.0650 | 21.2500 | 13.5650 | 20.9400 | 46.95% |
| 1994 | 12.7748 | 12.1900 | 14.3150 | 11.0000 | 14.2500 | 16.90% |
| 1993 | 13.4814 | 15.9400 | 15.9400 | 10.1250 | 12.1900 | -24.71% |
| 1992 | 17.9988 | 19.6250 | 20.0650 | 15.3750 | 16.1900 | -19.05% |
| 1991 | 16.9144 | 13.6900 | 20.1900 | 12.8150 | 20.0000 | 43.47% |
| 1990 | 12.3140 | 12.7500 | 14.5000 | 10.3150 | 13.9400 | 11.52% |
| 1989 | 10.7476 | 8.8100 | 12.8100 | 8.8100 | 12.5000 | 41.88% |
| 1988 | 10.3560 | 11.6850 | 12.9350 | 8.2500 | 8.8100 | -22.55% |
| 1987 | 12.1138 | 9.5000 | 14.5600 | 9.1850 | 11.3750 | 18.18% |
| 1986 | 9.0744 | 7.7500 | 10.5600 | 7.6250 | 9.6250 | 22.22% |
| 1985 | 7.3046 | 6.5650 | 8.3100 | 6.2500 | 7.8750 | 19.95% |
| 1984 | 8.1495 | 11.6250 | 12.2500 | 6.0000 | 6.5650 | -43.53% |
| 1983 | 13.3763 | 11.5925 | 15.6575 | 10.6850 | 11.6250 | -3.89% |
| 1982 | 9.6983 | 8.5625 | 12.6250 | 7.8125 | 12.0950 | 44.42% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $40.316B | $11.362B |
| Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $183.161B | 34.37 |
| Medtronic (MDT) | Ireland | $138.669B | 26.12 |
| Stryker (SYK) | United States | $76.844B | 29.80 |
| Boston Scientific (BSX) | United States | $53.421B | 30.86 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.798B | 0.00 |
| Terumo (TRUMY) | Japan | $30.009B | 38.36 |
| Zimmer Biomet Holdings (ZBH) | United States | $27.960B | 23.20 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $27.740B | 0.00 |
| ResMed (RMD) | United States | $24.494B | 35.51 |
| Sunny Optical Technology (SNPTF) | China | $16.508B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.353B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $14.962B | 67.67 |
| Insulet (PODD) | United States | $14.703B | 622.11 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $11.080B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $10.350B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $10.221B | 52.10 |
| Quidel (QDEL) | United States | $8.255B | 43.73 |
| William Demant Holdings (WILYY) | Denmark | $7.100B | 0.00 |
| Perrigo (PRGO) | Ireland | $6.174B | 10.60 |
| Hill-Rom Holdings (HRC) | United States | $5.465B | 13.56 |
| Canopy Growth (CGC) | Canada | $5.268B | 0.00 |
| Haemonetics (HAE) | United States | $4.417B | 29.43 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $4.388B | 0.00 |
| Neogen (NEOG) | United States | $3.998B | 65.56 |
| ICU Medical (ICUI) | United States | $3.904B | 29.79 |
| Envista Holdings (NVST) | United States | $3.806B | 25.96 |
| Abcam (ABCZY) | $3.251B | 0.00 | |
| TG Therapeutics (TGTX) | United States | $3.131B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.118B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.964B | 460.63 |
| NuVasive (NUVA) | United States | $2.522B | 35.15 |
| Agios Pharmaceuticals (AGIO) | United States | $2.380B | 0.00 |
| AtriCure (ATRC) | United States | $1.800B | 0.00 |
| DFB Healthcare Acquisitions (AHCO) | United States | $1.692B | 0.00 |
| NanoString Technologies (NSTG) | United States | $1.660B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.446B | 0.00 |
| MacroGenics (MGNX) | United States | $1.355B | 0.00 |
| Owens & Minor (OMI) | United States | $1.299B | 29.09 |
| Aphria (APHA) | Canada | $1.221B | 0.00 |
| InMode (INMD) | Israel | $1.154B | 29.10 |
| Cerus (CERS) | United States | $1.010B | 0.00 |
| Quanterix (QTRX) | United States | $0.932B | 0.00 |
| PetIQ (PETQ) | United States | $0.912B | 26.16 |
| BioLife Solutions (BLFS) | United States | $0.840B | 437.50 |
| Lantheus Holdings (LNTH) | United States | $0.815B | 11.30 |
| OraSure Technologies (OSUR) | United States | $0.804B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.722B | 16.52 |
| Meridian Bioscience (VIVO) | United States | $0.707B | 16.34 |
| LeMaitre Vascular (LMAT) | United States | $0.687B | 41.95 |
| Vapotherm (VAPO) | United States | $0.642B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.583B | 0.00 |
| Zynex (ZYXI) | United States | $0.580B | 50.61 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.566B | 80.02 |
| Omeros (OMER) | United States | $0.551B | 0.00 |
| Surmodics (SRDX) | United States | $0.522B | 57.22 |
| VAREX IMAGING (VREX) | United States | $0.472B | 20.46 |
| Viemed Healthcare (VMD) | United States | $0.341B | 12.19 |
| Cytosorbents (CTSO) | United States | $0.340B | 0.00 |
| HEXO (HEXO) | $0.318B | 0.00 | |
| Utah Medical Products (UTMD) | United States | $0.295B | 25.34 |
| Surface Oncology (SURF) | United States | $0.252B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.241B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.204B | 0.00 |
| Female Health (VERU) | United States | $0.180B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.164B | 0.00 |
| Chimerix (CMRX) | United States | $0.163B | 0.00 |
| Bovie Medical (APYX) | United States | $0.163B | 0.00 |
| Fonar (FONR) | United States | $0.141B | 12.46 |
| Exagen (XGN) | United States | $0.134B | 0.00 |
| Liberty Health Sciences (LHSIF) | United States | $0.133B | 0.00 |
| Evolus (EOLS) | United States | $0.130B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.105B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.094B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.084B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.075B | 0.00 |
| United-Guardian (UG) | United States | $0.069B | 15.40 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.067B | 0.00 |
| Brainsway (BWAY) | Israel | $0.063B | 0.00 |
| Nephros (NEPH) | United States | $0.058B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.051B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.048B | 9.09 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.035B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.019B | 0.00 |
| Conatus Pharmaceuticals (HSTO) | United States | $0.018B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.017B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.017B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
